Member Info for Scharnhorst

After waiting this long I’ll hang on for news. Can’t help thinking the board are in the Bahamas sipping Pina Coladas.

This one is well named Ahhhhhhhh
It's time for a new one Sooooooole

The PCR tests made good money. Not sure how much LFTs are adding to the coffers but at least they keep things ticking over. Not convinced they have any appeal for new investors though.

Must be a change of policy, blanking some sites. Bit of a slug fest today with volume perking up.

Indeed. Mercia promised they would become evergreen and they walk the talk.

I agree with your analysis barchid. The chart is showing a steady uptrend. I don’t see us closing the discount any time soon but we should be noticed by momentum investors. Plenty of upside at this price.

The CEO is too good to be sat there twiddling her thumbs. They’re working on something. But what?

The most interesting RNS was the change of broker.
"Their unifying passion is for exciting growth companies and the team has an enviable track record of growing companies from small beginnings into substantial enterprises – companies such as Domino’s Pizza, Learning Technologies Group and Rightmove. This track record has continued at Dowgate, with notable successes including Franchise Brands, National World and S4 Capital."

So, they spin out Netacea, the division with the most growth potential in which we now have a free ride, and sell the remainder of the business for 1.7x book value. Solid dealmaking.

It’s true they’re not forcing us to invest. Once invested, it’s reasonable to ask - what are they doing?

That defence of comparison with the Aim All share Index looks complacent now. Time for them to come out of hibernation.

Do you not think money would be better spent ensuring we have a sustainable business going forward? We've not been given any evidence that we have a viable business without selling covid tests. Giving away money made from covid doesn't seem sensible to me as the income is unreliable though it's been generated for longer than expected. The logical conclusion of going down that route is winding the business down and distributing proceeds to investors post covid. As things stand you'd be paying a pound to get 50p back.

Up to 30/6/22 they'd sold 1100 devices for total revenue of $982k
= $893/device
Note these sales were made with a gross loss, ie. it cost more to make them than they received for selling them.

Well said ace. I do wonder if directors are deliberately driving the price down. Remember one of the stated reasons for the capital reduction, if approved next week, is that the company can buy back its shares. I wouldn't put it past them.

It's obvious that if you cough or sneeze into a mask the concentration of droplets of mucus containing virus particles in the air around you will be reduced, and the plume will travel less far, compared to not wearing a mask. It's not preventative but it's doing some good and certainly not causing any harm.
Laughing at people wearing masks marks you down as an idiot. It's a personal choice.

Selling 750,000 at 1.3p seems odd given covid should be benefitting the company. Smells of capitulation. It’s not ideal that we haven’t heard anything but no news can be good news. Maybe they’re waiting for the outcome of the capital reduction court hearing around 17th January.

I can't comment barchid as I was thrown out of the Deutches Jungvolk for failing my grass up your parents badge.

Great to see a massive US company putting the cash down on a UK regional play. I do think there is takeover potential given the big discount to NAV, the cash generating fund management business which is ignored in the current value, and the interesting companies in their portfolio.

If only BlackRock had listened to dibs they could have waited and bought them for 25p.
I expect the dibs Tp index to be up another 25% next week.

I remember you making a good call on ODX dibs but if you want a fishing trip you’ll find better sport elsewhere.